BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35147539)

  • 1. Association of Antihypertensives and Cognitive Impairment in Long-Term Care Residents.
    Marcum ZA; Li Y; Lee SJ; Steinman MA; Graham L; Jing B; Fung K; Peralta CA; Odden MC
    J Alzheimers Dis; 2022; 86(3):1149-1158. PubMed ID: 35147539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment.
    Marcum ZA; Cohen JB; Zhang C; Derington CG; Greene TH; Ghazi L; Herrick JS; King JB; Cheung AK; Bryan N; Supiano MA; Sonnen JA; Weintraub WS; Williamson J; Pajewski NM; Bress AP;
    JAMA Netw Open; 2022 Jan; 5(1):e2145319. PubMed ID: 35089354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries.
    Marcum ZA; Gabriel N; Bress AP; Hernandez I
    JAMA Netw Open; 2023 Jan; 6(1):e2249370. PubMed ID: 36598787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Angiotensin II-Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial.
    van Dalen JW; Marcum ZA; Gray SL; Barthold D; Moll van Charante EP; van Gool WA; Crane PK; Larson EB; Richard E
    Neurology; 2021 Jan; 96(1):e67-e80. PubMed ID: 33154085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort.
    Liampas I; Hatzimanolis A; Siokas V; Yannakoulia M; Kosmidis MH; Sakka P; Hadjigeorgiou GM; Scarmeas N; Dardiotis E
    J Alzheimers Dis; 2022; 89(2):709-719. PubMed ID: 35912747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: impact of drug class on adherence to antihypertensives.
    Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
    Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study.
    Drucker AM; Hollestein L; Na Y; Weinstock MA; Li WQ; Abdel-Qadir H; Chan AW
    CMAJ; 2021 Apr; 193(15):E508-E516. PubMed ID: 33846199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia.
    Deng Z; Jiang J; Wang J; Pan D; Zhu Y; Li H; Zhang X; Liu X; Xu Y; Li Y; Tang Y;
    Hypertension; 2022 Oct; 79(10):2159-2169. PubMed ID: 35766029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive medication classes and the risk of dementia over a decade of follow-up.
    Schroevers JL; Eggink E; Hoevenaar-Blom MP; Van Dalen JW; Van Middelaar T; Van Gool WA; Richard E; Moll Van Charante EP
    J Hypertens; 2023 Feb; 41(2):262-270. PubMed ID: 36394298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
    Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
    Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service.
    Kim J; Kim DW; Kim KI; Kim HB; Kim JH; Lee YG; Byeon KH; Cheong HK;
    J Korean Med Sci; 2020 Jun; 35(25):e232. PubMed ID: 32597045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
    Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
    J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
    Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
    Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
    Vila-Corcoles A; Satue-Gracia E; Ochoa-Gondar O; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Rovira-Veciana D; Basora-Gallisa J
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1379-1388. PubMed ID: 32710674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
    Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.